- Home
- Labeler Index
- Celltrion Usa, Inc.
- 72606-023
- NDC Crossover: 72606-023 Yuflyma
NDC Crossover 72606-023 Yuflyma
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Adalimumab
Explore similar products and medications to NDC 72606-023 Yuflyma a human prescription drug with other products crossover matching the same product name (Yuflyma) or generic name (Adalimumab), and the same administration route (subcutaneous) or dosage form (injection). This comprehensive list of related drugs for easy comparison is ideal for healthcare professionals & patients seeking alternatives.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 72606-022 | Adalimumab | Adalimumab-aaty | Injection | Subcutaneous | Celltrion Usa, Inc. | Human Prescription Drug |
| 72606-024 | Yuflyma | Adalimumab | Injection | Subcutaneous | Celltrion Usa, Inc. | Human Prescription Drug |
| 72606-030 | Yuflyma | Adalimumab | Injection | Subcutaneous | Celltrion Usa, Inc. | Human Prescription Drug |
| 72606-040 | Adalimumab | Adalimumab-aaty | Injection | Subcutaneous | Celltrion Usa, Inc. | Human Prescription Drug |
| 72606-041 | Adalimumab | Adalimumab-aaty | Injection | Subcutaneous | Celltrion Usa, Inc. | Human Prescription Drug |